// App-Quantinova.ai

: Enthesitis in Patients With Psoriatic Arthritis Treated With Secukinumab or Adalimumab: a Post Hoc Analysis of EXCEED

Researchers

Presenter

  • Gurjit S. Kaeley

Principal Investigators

  • Georg Schett

  • Philip G. Conaghan

  • Dennis McGonagle

  • Frank Behrens

  • Philippe Goupille

  • Corine Gaillez

  • Bhumik Parikh

  • Xiangyi Meng

  • Catherine Bakewell

Medical Centers

  • University of Florida, Cainsvillle, FL

  • Friedrich-Alexander-Universität Erlangen, Nürnberg und Universitätsklinikum Erlangen, Erlangen, Germany

  • National Institute for Health Research- Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

  • Division of Rheumatology and Fraunhofer IME-Project-Group Translational Medicine and Pharmacology, Goethe University, Frankfurt, Germany

  • University Hospital of Tours, University of Tours, Tours, France

  • Novartis AG, Basel, Switzerland

  • Novartis Pharmaceutical Corporation, East Hanover, NJ

  • Intermountain Healthcare Medical Group, Salt Lake City, UT

Locations

  • France

  • Germany

  • Switzerland

  • United Kingdom

  • United States

Companies

  • Novartis AG

Study Components

Therapeutic Area

  • Musculoskeletal

  • Dermatology

Disease

  • Psoriatic arthritis

  • Spondyloarthritis

Biomarkers

  • N/A

Drug/Treatment

  • secukinumab

  • Adalimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • NCT02745080

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved